Foghorn Therapeutics (FHTX) Other Working Capital Changes (2019 - 2026)

Foghorn Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 45.1% year-over-year to -$3.3 million in Q1 2026; TTM through Mar 2026 was -$25.4 million, a 7.9% decrease from a year earlier, with the FY2025 full-year figure at -$30.9 million, down 36.75% from the prior year.
• Other Working Capital Changes rose to -$3.3 million in Q1 2026 per FHTX's latest filing, from -$21.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.4 million in Q4 2022 and bottomed at -$1.3 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is -$465000.0 (2024), against an average of -$263941.2.
• Biggest YoY gain for Other Working Capital Changes was 598.97% in 2023; the steepest drop was 1419.09% in 2023.
• Year by year, Other Working Capital Changes stood at -$4.2 million in 2022, then soared by 598.97% to $20.9 million in 2023, then plunged by 113.68% to -$2.9 million in 2024, then plunged by 645.8% to -$21.3 million in 2025, then soared by 84.66% to -$3.3 million in 2026.
• Per Business Quant, the three latest FHTX Other Working Capital Changes figures stand at -$3.3 million (Q1 2026), -$21.3 million (Q4 2025), and $7.7 million (Q3 2025).